Prediction of antimicrobial resistance in people living with cystic fibrosis using machine learning

Jiang, J, Naik, A, Nazareth, D, Wat, D, Hyde, G, Fothergill, J, Benabidallah, S, Lip, GYH ORCID: 0000-0002-7566-1626, Ortega-Martorell, S ORCID: 0000-0001-9927-3209, Olier, I ORCID: 0000-0002-5679-7501 and Frost, F Prediction of antimicrobial resistance in people living with cystic fibrosis using machine learning. MedComm. ISSN 2688-2663 (Accepted)

Preview

Text Prediction of antimicrobial resistance in people living with cystic fibrosis using machine learning.pdf - Accepted Version Available under License Creative Commons Attribution. Download (1MB) | Preview

Abstract

Antimicrobial resistance (AMR) is a growing challenge in people living with cystic fibrosis (pwCF), who often experience chronic lung infection and repeated antibiotic exposure. Because routine antibiotic susceptibility testing often takes several days, treatment is frequently started before current resistance profiles are available. We assessed whether routinely collected electronic healthcare record data could predict antibiotic resistance in sputum cultures from adults with CF. In this retrospective single-centre study, 12,618 sputum cultures from 209 pwCF between 2012 and 2022 were linked with 63,823 days of intravenous antibiotic exposure, spirometry, demographic characteristics, microbiology results and historical resistance data. Five machine learning models were trained and evaluated with patient-level splitting and cross-validation to predict resistance to ciprofloxacin, ceftazidime, meropenem, piperacillin/tazobactam and tobramycin. Gradient boosting showed the most consistent performance, with AUCs of 0.75–0.80 across antibiotics. Model discrimination was broadly similar in cultures with and without Pseudomonas aeruginosa, except for ceftazidime and meropenem. SHAP analysis suggested that longer-term resistance history was more informative than recent results. These findings support the feasibility of using EHR-derived data to estimate AMR before culture results are available, but external validation, broader antibiotic exposure data and assessment of temporal dataset shift are needed before clinical use.

Item Type:	Article
Subjects:	Q Science > QA Mathematics > QA75 Electronic computers. Computer science R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine
Divisions:	Computer Science and Mathematics Nursing and Advanced Practice
Publisher:	Wiley
Date of acceptance:	9 June 2026
Date of first compliant Open Access:	17 June 2026
Date Deposited:	17 Jun 2026 14:11
Last Modified:	17 Jun 2026 14:11
URI:	https://researchonline.ljmu.ac.uk/id/eprint/28856

View Item